Regeneron Pharmaceuticals

Regeneron Pharmaceuticals as of June 30, 2026

Portfolio Holdings for Regeneron Pharmaceuticals

Regeneron Pharmaceuticals holds 3 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Parabilis Medicines Common Stock 64.4 $114M 4.2M 27.37
Intellia Therapeutics Common Stock (NTLA) 35.4 $63M 3.7M 16.92
Adicet Bio Common Stock (ACET) 0.3 $523k 61k 8.64